Patent
1978-11-20
1980-05-06
Behrend, Harvey E.
176 16, G21G 110
Patent
active
042016258
ABSTRACT:
A target containing vanadium, either of natural isotopic constitution or enriched either with respect to .sup.50 vanadium or .sup.51 vanadium, is bombarded with .sup.3 helium of an energy of about 14 MeV producing .sup.52 manganese by nuclear reaction from both of these isotopes of vanadium. After a waiting period for the disappearance of short-lived intermediates, the target foil is dissolved in acid and the .sup.52 manganese is extracted with a solution of a hydroxychinolin in chloroform. The oxinate complex of .sup.52 manganese thus extracted can be used directly as a source of .sup.52 manganese in the preparation of compositions for radiochemical or radiopharaceutical purposes.
REFERENCES:
"Kunstliche Radioaktive Isotope in Physiologie, Diagnostik und Therapie", Schwiegls & Turba, 1961, p. 259.
"Interne Tumortherapie mit Kunstlich Radioaktiven Isotopen", Muller, p. 798.
"Blutkrankheiten", Heilmeyer & Keiderling, pp. 834, 862.
"Kernenergie", vol. 5, Issue 12/62, pp. 853-859.
"Radioisotope Production & Quality Control", IAEA, Vienna, 1971 (ST1/DOC-10/128), pp. 808-812.
"Atomwirtschaft", 1/78, pp. 36-39, article by Harder et al.
Erdtmann Gerhard
Kuppers Gottfried
Petri Hermann
Sastri Chaturvedula
Behrend Harvey E.
Kernforschungsanlage Julich Gesellschaft mit beschrankter Haftun
LandOfFree
Process for producing .sup.52 manganese does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing .sup.52 manganese, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing .sup.52 manganese will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1003910